University of Michigan

Safe busing during COVID-19: The science behind U-M's changes

19-Aug-2020 10:20 AM EDT, by University of Michigan

Newswise — In an effort to design a safe campus bus system for the fall semester in light of COVID-19, University of Michigan researchers simulated how aerosol particles exhaled from passengers sitting in any seat would travel through the vehicle under different conditions. 

That's just one facet of the broad-based work engineering researchers have undertaken in recent months to quantify risks and provide data to inform university busing decisions. 

In addition to developing physics-based computer models of aerosol dispersion—and validating them with experiments using water vapor—they also used algorithms to overhaul routes, reducing passengers' time on buses to minimize possible exposure to the virus. The university's bus fleet provided an estimated 8 million rides between its three Ann Arbor campuses last year.

After considering the researchers' conclusions, U-M announced recently that beginning Aug. 24, all bus riders and drivers must wear face coverings, windows will remain open, capacity will be reduced to nearly half and all previous routes will be replaced by a high-frequency hub-and-spoke routing system, among other changes.

The research team, which involved faculty from across the College of Engineering, explored how to apply public health guidance that riders should wear masks and limit the length of each trip to 15 minutes or less.

Shortening rides presented a challenge, as the pre-COVID bus system used long routes designed to minimize transfers. So they turned to Siqian Shen, an associate professor of industrial and operations engineering, who studies design and optimization of complex systems, including transportation networks.

Shen and her team employed mathematical modeling and optimization techniques to design a hub-and-spoke system of direct routes with fewer stops. Not only does it keep rides under 15 minutes, it enables more frequent service with the same number of buses, reducing wait times as well as the number of passengers on each bus. 

"We conducted a wide range of simulation tests based on possible demand patterns in the fall semester. Our results show that the new design can satisfy peak-hour demand, and will help passengers stay safe by having all routes shorter than 15 minutes," Shen said. "Most passengers will still only take one bus to reach their destination and all passengers can find nearby bus stops within five minutes' walk of their starting and ending locations."

Next, the team worked to quantify and reduce risks to passengers and drivers. They wanted to know more about exactly how any virus particles would travel around the bus and how to slow their spread. They knew that COVID-19 is transmitted mainly through tiny, aerosolized droplets infected people expel, but beyond that, the science is thin because the virus itself is so new.

"We've really only been learning about this virus for the last few months, and in academic terms, that's a split second," said Jesse Capecelatro, an assistant professor of mechanical engineering who specializes in "messy turbulent flows" and simulating the behavior of fluids made of two phases of matter—in this case, particles suspended in air.

"There exists very little data on how infectious aerosols are transmitted on a bus, and how different factors contribute to the risk of infection. The most documented case of COVID-19 transmission in a situation like this is from an outbreak on a long-distance coach in Hunan, China. 

"Security cameras showed that eight of the 45 passengers were infected, despite not getting in close contact with the infected individual. Based on this and recent research from the literature, we are able to make conservative estimates when defining and quantifying risk."

While there is still much research to be done on how COVID-19 spreads, public health estimates suggest that the maximum number of particles a person could inhale without getting sick is more than one but less than 1,000, the researchers said. 

With that information, Kevin Maki, the Richard B. Couch Development Professor of Marine Hydrodynamics, used his large-scale fluid dynamics expertise to model how many aerosol particles a sick passenger would be likely to expel and how they would travel through the interior of a bus. 

Mechanical engineering professor Andre Boehman explored aerosol transport in the buses and provided experimental data to validate the models by releasing vapor from a theatrical smoke machine on an actual U-M bus. Using two aerosol size analyzers normally used to analyze car exhaust, Boehman's group tracked the dispersion, dilution and fate of the vapor aerosol.  

Using both computer models and Boehman's experimental data, the team then simulated different interventions to measure how they could affect the number of viral particles on the bus—windows open versus windows closed, driving versus stationary, masks versus no masks, and many other scenarios. They also looked for ways to prevent exposure of the driver to aerosols emitted by passengers, as the long hours drivers spend on the bus put them at a higher risk of infection.

The modeling showed that simple measures make a big difference: Opening the windows, for example, cuts aerosol concentrations in half. Wearing masks is the most important step of all, as it confines the travel of particles from a passenger to only a few inches, if the mask is well fitted. And closing the HVAC vent that blows on the driver dramatically reduces their risk of becoming infected. 

Ultimately, the team developed a series of interventions that limited the number of infected particles likely to be inhaled on a 15-minute ride. Without these steps, one sick passenger could lead to many others inhaling more than 100 particles—a relatively low number but still worrisome. With the strategies in place, if one sick passenger were to ride, most other passengers would be expected to inhale less than two viral particles on average, and all inhale far less than 100, the researchers said. 

"We looked at each seating position and we modeled how the aerosols we could expect to be emitted from an infected passenger travel through the bus, and how many aerosols each passenger would be likely to inhale on a 15-minute ride," Maki said. 

"Our simulations show that on a 15-minute bus ride, if you're wearing a mask, you're at very, very low risk with the changes that are being implemented. If everyone is wearing a well-fitted mask, you could pack in very tightly and still be safe, at least for the length of time of the new bus routes."

The task of turning the team's findings into a working bus system fell to Steve Dolen, the executive director of U-M Logistics, Transportation and Parking. Dolen led the reconfiguration of buses to accommodate a reduced capacity of 40 passengers, the installation of partitions between drivers and passengers, the deployment of a group of volunteer bus stop greeters to enforce mask mandates and a raft of other changes.

"A tremendous amount of work has gone into planning for the fall semester and it has been a truly collaborative effort led by a great team in the College of Engineering," Dolen said. "They were committed from the beginning of the effort to help us solve how we would operate." 

Written by Gabe Cherry


Filters close

Showing results

110 of 5634
Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:00 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.

Released: 13-May-2021 9:00 AM EDT
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

Released: 13-May-2021 8:00 AM EDT
Dental procedures during pandemic are no riskier than a drink of water
Ohio State University

A new study’s findings dispel the misconception that patients and providers are at high risk of catching COVID-19 at the dentist’s office.

Newswise:Video Embedded lung-damage-not-the-culprit-for-post-covid-exercise-limitations
Released: 13-May-2021 7:00 AM EDT
Lung Damage Not the Culprit for Post-COVID Exercise Limitations
American Physiological Society (APS)

A new study suggests the lungs may not be the main factor that reduce exercise ability in people recovering from severe COVID-19. Anemia and muscle dysfunction also play a role. The study is published ahead of print in the Journal of Applied Physiology. It was chosen as an APSselect article for May.

Newswise:Video Embedded australia-accelerates-new-covid-19-vaccine-to-fight-mutant-strains
Released: 13-May-2021 2:05 AM EDT
Australia accelerates new COVID-19 vaccine to fight mutant strains
University of South Australia

A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus.

Released: 12-May-2021 5:10 PM EDT
Understanding SARS-COV-2 proteins is key to improve therapeutic options for COVID-19
Bentham Science Publishers

COVID-19 has had a significant impact since the pandemic was declared by WHO in 2020, with over 3 million deaths and counting, Researchers and medical teams have been hard at work at developing strategies to control the spread of the infection, caused by SARS-COV-2 virus and treat affected patients.

Showing results

110 of 5634